U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417683) titled 'Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity' on Feb. 10.
Brief Summary: Approval study Trans-Duodenal Barrier The goal of this clinical trial is to determin the safety and performance of the newly developed Trans-Duodenal Barrier in adult Tryp 2 diabetic and obese patients.
The Trans-Duodenal Barrier is an endoscopic implant which can be placed to the gastric outlet and the upper small bowel by interventional endoscopy. It consists of a 60 cm long foil tube , a transpyloric shaft and and two ringlike balloons to fix it at the pylorus. It will be removed after 6 months via gastroscopy.
The mai...